Literature DB >> 19808647

Type I interferon modulates monocyte recruitment and maturation in chronic inflammation.

Pui Y Lee1, Yi Li, Yutaro Kumagai, Yuan Xu, Jason S Weinstein, Erinn S Kellner, Dina C Nacionales, Edward J Butfiloski, Nico van Rooijen, Shizuo Akira, Eric S Sobel, Minoru Satoh, Westley H Reeves.   

Abstract

Chronic inflammation is characterized by continuous recruitment and activation of immune cells such as monocytes in response to a persistent stimulus. Production of proinflammatory mediators by monocytes leads to tissue damage and perpetuates the inflammatory response. However, the mechanism(s) responsible for the sustained influx of monocytes in chronic inflammation are not well defined. In chronic peritonitis induced by pristane, the persistent recruitment of Ly6C(hi) inflammatory monocytes into the peritoneum was abolished in type I interferon (IFN-I) receptor-deficient mice but was unaffected by the absence of IFN-gamma, tumor necrosis factor-alpha, interleukin-6, or interleukin-1. IFN-I signaling stimulated the production of chemokines (CCL2, CCL7, and CCL12) that recruited Ly6C(hi) monocytes via interactions with the chemokine receptor CCR2. Interestingly, after 2,6,10,14-tetramethylpentadecane treatment, the rapid turnover of inflammatory monocytes in the inflamed peritoneum was associated with a lack of differentiation into Ly6C(lo) monocytes/macrophages, a more mature subset with enhanced phagocytic capacity. In contrast, Ly6C(hi) monocytes differentiated normally into Ly6C(lo) cells in IFN-I receptor-deficient mice. The effects of IFN-I were specific for monocytes as granulocyte migration was unaffected in the absence of IFN-I signaling. Taken together, our findings reveal a novel role of IFN-I in promoting the recruitment of inflammatory monocytes via the chemokine receptor CCR2. Continuous monocyte recruitment and the lack of terminal differentiation induced by IFN-I may help sustain the chronic inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808647      PMCID: PMC2774066          DOI: 10.2353/ajpath.2009.090328

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

2.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes.

Authors:  C Chizzolini; R Rezzonico; C De Luca; D Burger; J M Dayer
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 4.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

5.  Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.

Authors:  H B Richards; M Satoh; J C Jennette; B P Croker; H Yoshida; W H Reeves
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.

Authors:  Vladimir Toshchakov; Bryan W Jones; Pin-Yu Perera; Karen Thomas; M Joshua Cody; Shuling Zhang; Bryan R G Williams; Jennifer Major; Thomas A Hamilton; Matthew J Fenton; Stefanie N Vogel
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

8.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

9.  Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.

Authors:  Alexander Niessner; Min Sun Shin; Olga Pryshchep; Jörg J Goronzy; Elliot L Chaikof; Cornelia M Weyand
Journal:  Circulation       Date:  2007-10-15       Impact factor: 29.690

10.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  94 in total

1.  Peritoneal macrophage from male and female SJL mice differ in IL-10 expression and macrophage maturation.

Authors:  Shabbir Hussain; Stephen A Stohlman
Journal:  J Leukoc Biol       Date:  2012-01-18       Impact factor: 4.962

2.  Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.

Authors:  Haoyang Zhuang; Shuhong Han; Pui Y Lee; Ravil Khaybullin; Stepan Shumyak; Li Lu; Amina Chatha; Anan Afaneh; Yuan Zhang; Chao Xie; Dina Nacionales; Lyle Moldawer; Xin Qi; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2017-05-05       Impact factor: 10.995

3.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 4.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

5.  Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.

Authors:  Yuan Xu; Pui Y Lee; Yi Li; Chao Liu; Haoyang Zhuang; Shuhong Han; Dina C Nacionales; Jason Weinstein; Clayton E Mathews; Lyle L Moldawer; Shi-Wu Li; Minoru Satoh; Li-Jun Yang; Westley H Reeves
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

6.  Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.

Authors:  Shirley Dehn; Edward B Thorp
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

Review 7.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

8.  Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.

Authors:  Matthew B Buechler; Griffin M Gessay; Shivani Srivastava; Daniel J Campbell; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2015-09-14       Impact factor: 5.532

9.  The cytokine language of monocytes and macrophages in systemic sclerosis.

Authors:  Romy B Christmann; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2010-10-29       Impact factor: 5.156

Review 10.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.